Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
8
Next >
Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy
June 14, 2022
Tickers
CNCE
INCY
LLY
PFE
Tags
FDA
General
hair loss treatment
From
Benzinga
In a shaky economy, cash is king — and these S&P 500 companies have it, says Barclays
June 09, 2022
Tickers
AAPL
AKAM
AMZN
ATVI
Tags
LYV
ATVI
VRTX
From
MarketWatch
CHMP Backs Approval of Lilly/Incyte's Olumiant For Patchy Hair Loss
May 20, 2022
Tickers
INCY
LLY
Tags
Market News
why it's moving
INCY
From
Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2022
May 18, 2022
Tickers
AXSM
INCY
JAZZ
NVS
Tags
INCY
AXSM
Recent Press Releases
From
Motley Fool
Was This Acquisition a Smart Move for GlaxoSmithKline?
May 14, 2022
Tickers
GSK
INCY
SRRA
Tags
SRRA
GSK
Recent Press Releases
From
Motley Fool
Mizuho Sees Relief For This Small-Cap Stock After Patent Legal Overhang Lifted
May 13, 2022
Tickers
CNCE
INCY
Tags
Analyst Ratings
Analyst Color
Market News
From
Benzinga
Why CTI Biopharma Stock Is Surging Today
May 13, 2022
Tickers
CTIC
INCY
Tags
CTIC
INCY
Recent Press Releases
From
Motley Fool
Amid Slowing Sales at Home, Innovent Biologics Stumbles Overseas
May 13, 2022
Tickers
ASIA
BGNE
CHRS
HCM
Tags
LLY
INCY
Benzinga
From
Benzinga
WHO head censored in China after criticizing zero-COVID policy, and U.S. cases up 52% from two weeks ago
May 11, 2022
Tickers
EBS
INCY
LLY
MSFT
Tags
LLY
INCY
MSFT
From
MarketWatch
FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) for Hospitalized Patients with COVID-19
May 11, 2022
Tickers
INCY
LLY
Tags
News
Biotech
Health Care
From
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Tickers
ABUS
AGIO
ALDX
ARGX
Tags
AGIO
Benzinga
Biotech
From
Benzinga
4 Analysts Have This to Say About Incyte
May 04, 2022
Tickers
INCY
Tags
Market News
INCY
Benzinga
From
Benzinga
Despite Q1 Earnings Miss, Incyte Shares Jump On Revised FY22 Sales Guidance
May 03, 2022
Tickers
INCY
Tags
Briefs
Benzinga
Movers
From
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Tickers
ACAD
AQST
BIIB
BLTE
Tags
EXEL
ESPR
Trading Ideas
From
Benzinga
Incyte: Q1 Earnings Insights
May 03, 2022
Tickers
INCY
Tags
Earnings
INCY
Benzinga
From
Benzinga
Global Cord Blood Enters Therapy Market Via Cellenkos Acquisition For Over $600M
May 02, 2022
Tickers
CO
INCY
Tags
Small Cap
General
Briefs
From
Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
May 02, 2022
Tickers
AGTC
AMGN
AMRN
ATHX
Tags
PYPD
FDA
IBB
From
Benzinga
3 Nasdaq Stocks to Buy Now for Growth
May 01, 2022
Tickers
AMZN
AVGO
BLK
FTXL
Tags
QCOM
INCY
FTXL
From
InvestorPlace
EMA's Advisory Committee Backs Approval Of Incyte's Capmatinib In Advanced Lung Cancer Setting
April 22, 2022
Tickers
INCY
NVS
Tags
INCY
Benzinga
Health Care
From
Benzinga
How To Attend Incyte Q1 2022 Earnings Conference Call
April 21, 2022
Tickers
INCY
Tags
BZI/CONF
Market News
INCY
From
Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Tickers
BGNE
BTAI
CCCC
CTXR
Tags
NVS
CTXR
Market News
From
Benzinga
This Favorable Sign Appears On Incyte's Chart
April 05, 2022
Tickers
INCY
Tags
Benzinga
Trading Ideas
INCY
From
Benzinga
Incyte's Ruxolitinib Shows Further Improvement In Facial, Total Body Re-pigmentation At 52 Weeks In Skin Disorder
March 28, 2022
Tickers
INCY
Tags
Market News
General
Biotech
From
Benzinga
Incyte-Lilly's Olumiant Continue To Show Improved Scalp, Eyebrows, Eyelash Hair Regrowth At 52 Weeks
March 28, 2022
Tickers
INCY
LLY
Tags
Market News
General
Biotech
From
Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
March 24, 2022
Tickers
INCY
NVO
NVS
Tags
Recent Press Releases
NVS
Market News
From
Motley Fool
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
March 23, 2022
Tickers
APTO
APTX
ARGX
BMY
Tags
NAVB
RMED
APTO
From
Benzinga
MorphoSys-Incyte Partnered Minjuvi Temporarily Approved In Switzerland
March 23, 2022
Tickers
INCY
MOR
Tags
Small Cap
General
Market News
From
Benzinga
This Dividend Growth Stock Is a Screaming Buy
March 15, 2022
Tickers
INCY
LLY
Tags
Recent Press Releases
Market News
INCY
From
Motley Fool
FDA Extends Decision Date For Incyte's Ruxolitinib In Vitiligo Skin Disorder
March 14, 2022
Tickers
INCY
Tags
Briefs
News
Biotech
From
Benzinga
Insiders Buy More Than $80M Of 3 Stocks
March 11, 2022
Tickers
DASH
INCY
RILY
Tags
Benzinga
Insider Buying
Long Ideas
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.